Importance of Virtual Platforms in Improving the Reproducibility of Data in Cancer Research

Document Type : Commentary

Authors

Department of Immunopathology, Post Graduate Institute of Medical Education & Research, Chandigarh, India

Abstract

Virtual platforms have revolutionized distance education, making it accessible worldwide and empowering scientists, academicians, and researchers to access knowledge effortlessly. These platforms provide flexibility, allowing the users to tailor their learning experience to their needs and integrating knowledge into their work. Reproducibility is crucial in cancer research, and researchers integrate data analysis into virtual or electronic learning (E-learning) platforms to facilitate replication and verification, promoting transparency and reliability. This integration enhances accessibility and enables collaboration among scientists and stakeholders working to combat cancer. Virtual learning offers written and audio-visual communication benefits facilitated by electronic and web-enabling advancements. In the dynamic virtual realm, researchers transcend limitations, exchange knowledge, and push the boundaries of cancer research. Virtual platforms provide time efficiency and financial freedom, while advanced tools support data analysis and facilitate new insights. These tools unlock hidden patterns and accelerate the pace of discovery. The digital ecosystem generates new ideas, improves research methodology, and enhances research quality. Limitless collaboration and advanced tools propel cancer research, unravelling complex data with precision and innovation. The potential of cyberspace to revolutionize scientific research in the future, therefore, is promising.

Keywords

References

  1. Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149(4):778-89. doi: 10.1002/ijc.33588. PubMed PMID: 33818764.
  2. Six factors affecting reproducibility in life science research and how to handle them. Nature Research Custom; [Cited 2023 June 11]. Available from: https://www.nature.com/articles/d42473-019-00004-y.
  3. Reynolds LM, Cavadino A, Chin S, Little Z, Akroyd A, Tennant G, Dobson R, Broom R, Gautier A. The benefits and acceptability of virtual reality interventions for women with metastatic breast cancer in their homes; a pilot randomised trial. BMC Cancer. 2022;22(1):360. doi: 10.1186/s12885-021-09081-z. PubMed PMID: 35366823; PubMed Central PMCID: PMC8976512.
  4. Fanelli D. “Positive” results increase down the Hierarchy of the Sciences. PLoS One. 2010 Apr 7;5(4):e10068. doi: 10.1371/journal.pone.0010068. PubMed PMID: 20383332; PubMed Central PMCID: PMC2850928.
  5. Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2(8):e124. doi: 10.1371/journal.pmed.0020124. Erratum in: PLoS Med. 2022 Aug 25;19(8):e1004085. PubMed PMID: 16060722; PubMed Central PMCID: PMC1182327.
  6. Sterling D, Rosenbaum WL, Weinkam JJ. Publication Decisions Revisited: The Effect of the Outcome of Statistical Tests on the Decision to Publish and Vice Versa. Am Stat. 1995;49(1):108-12. doi: 10.1080/00031305.1995.10476125.
  7. Errington TM, Denis A, Perfito N, Iorns E, Nosek BA. Challenges for assessing replicability in preclinical cancer biology. Elife. 2021;10:e67995. doi: 10.7554/eLife.67995. PubMed PMID: 34874008; PubMed Central PMCID: PMC8651289.
  8. Vaona A, Banzi R, Kwag KH, Rigon G, Cereda D, Pecoraro V, Tramacere I, Moja L. E-learning for health professionals. Cochrane Database Syst Rev. 2018;1(1):CD011736. doi: 10.1002/14651858.CD011736.pub2. PubMed PMID: 29355907; PubMed Central PMCID: PMC6491176.
  9. Ioannidis JP. How to make more published research true. PLoS Med. 2014;11(10):e1001747. doi: 10.1371/journal.pmed.1001747. PubMed PMID: 25334033; PubMed Central PMCID: PMC4204808.
  10. Quintana DS. From preregistration to publication: a non-technical primer for conducting a meta-analysis to synthesize correlational data. Front Psychol. 2015;6:1549. doi: 10.3389/fpsyg.2015.01549. PubMed PMID: 26500598; PubMed Central PMCID: PMC4597034.
  11. Kaplan RM, Irvin VL. Likelihood of Null Effects of Large NHLBI Clinical Trials Has Increased Over Time. PLoS One. 2015;10(8):e0132382. doi: 10.1371/journal.pone.0132382. PubMed PMID: 26244868; PubMed Central PMCID: PMC4526697.
  12. Macleod MR, Michie S, Roberts I, Dirnagl U, Chalmers I, Ioannidis JP, Al-Shahi Salman R, Chan AW, Glasziou P. Biomedical research: increasing value, reducing waste. Lancet. 2014;383(9912):101-4. doi: 10.1016/S0140-6736(13)62329-6. PubMed PMID: 24411643.
  13. Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA. 2004;291(20):2457-65. doi: 10.1001/jama.291.20.2457. PubMed PMID: 15161896.
  14. Krzyszczyk P, Acevedo A, Davidoff EJ, Timmins LM, Marrero-Berrios I, Patel M, White C, Lowe C, Sherba JJ, Hartmanshenn C, O’Neill KM, Balter ML, Fritz ZR, Androulakis IP, Schloss RS, Yarmush ML. The growing role of precision and personalized medicine for cancer treatment. Technology (Singap World Sci). 2018;6(3-4):79-100. doi: 10.1142/S2339547818300020. PubMed PMID: 30713991; PubMed Central PMCID: PMC6352312.
  15. Brika SKM, Chergui K, Algamdi A, Musa AA, Zouaghi R. E-Learning Research Trends in Higher Education in Light of COVID-19: A Bibliometric Analysis. Front Psychol. 2022;12:762819. doi: 10.3389/fpsyg.2021.762819. PubMed PMID: 35308075; PubMed Central PMCID: PMC8929398.
Interdisciplinary Journal of Virtual Learning in Medical Sciences
Volume 14, Issue 3 - Serial Number 54
September 2023
Pages 244-249

Files

History

  • Receive Date: 17 February 2023
  • Revise Date: 03 March 2023
  • Accept Date: 16 March 2023
  • Publish Date: 01 September 2023

Share

How to cite

Statistics